CBG research from KBW12 Feb 2025 13:21
Summary
CBG published an H125 trading statement to 31 January this morning, ahead of results scheduled for 18 March 2025.
The key news is that they expect to take a Motor finance redress provision of up to £165m. This is based on a probability weighting of possible outcomes and knocks -1.5% off CET1 (pro forma 12.0%), although expect FY25 CET1 to recover to c.13%. It is tough to assess the adequacy of this provision as no additional information is provided around the amount of lending, average commission rates, etc. (KBWe total £465m). However, we note that it equates to c.8% of their current loan book, compared with the recent Santander provision at c.6% or FirstRand at c.11%. Elsewhere, first-half operating performance looks broadly in line with consensus. However, loan volumes look light and management do highlight a risk of additional legal and professional fees in H2 as well as potential impacts from new motor finance lending requirements. With that in mind, we downgrade adjusted EPS25e -9% to 61.4p (from 67.6p), adjusted EPS26e -13% to 66.2p (from 76.6p), and adjusted EPS27e -10% to 80.2p (from 88.7p).
Overall - CBG shares have rallied strongly this year (YTD +55%) as market expectations have grown that any motor finance redress liability will be lower than worst fears. However, the shares are still not expensive, trading on consensus PE26e 5.3x or PTBV24e 0.4x - a discount to book value equivalent to c.£830m of market value. We do not believe that the £165m provision will ultimately be sufficient, but it is a welcome step in the right direction and the shares continue to discount a potential liability considerably in excess of KBWe £460m. Reiterate Outperform, TP440p.